SB 181 Arkansas Senate · 2023 Regular Session

TO MANDATE COVERAGE FOR USE OF INTRAVENOUS IMMUNOGLOBULIN TO TREAT CERTAIN PEDIATRIC DISORDERS CAUSED BY INFECTIONS; AND TO DECLARE AN EMERGENCY.

Bill status signed all 5 stages cleared

Introduction

Jan 2023

Committee Review

Apr 2023

Senate Passage

Apr 2023

House Passage

Apr 2023

Signed into Law

Apr 2023

Introduced Jan 27, 2023 Signed Apr 13, 2023

Floor votes · Senate Apr 3, 2023 · House Apr 6, 2023

How they voted

21–0

Passed

Total votes 21

Apr 3, 2023

D Democratic2

2 Yea

100% Yea

R Republican19

19 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 13, 2023

Signed into law

Notification that SB181 is now Act 876

upper

Apr 7, 2023

Upper · Passed

EMERGENCY CLAUSE ADOPTED

upper

Apr 7, 2023

Upper · Passed

Read the third time and passed.

upper

Apr 7, 2023

Upper · Passed

Returned by the Committee with the recommendation that it Do Pass concur in House Amendment No. 1

upper

Apr 6, 2023

Committee

Re-referred to INSURANCE & COMMERCE - SENATE

upper

Apr 6, 2023

Upper · Passed

Returned from the House as passed, as amended # 1

upper

Apr 6, 2023

Lower · Passed

EMERGENCY CLAUSE ADOPTED

lower

Apr 6, 2023

Lower · Passed

Read the third time and passed and ordered transmitted to the Senate.

lower

Apr 5, 2023

Introduced

Amendment No. 1 read and adopted and the bill ordered engrossed.

lower

Apr 5, 2023

Lower · Passed

Returned by the Committee with the recommendation that it do pass as amended 1

lower

Apr 3, 2023

Upper · Passed

EMERGENCY CLAUSE ADOPTED

upper

Apr 3, 2023

Upper · Passed

Read the third time and passed.

upper

Mar 31, 2023

Upper · Passed

Returned by the Committee with the recommendation that it Do Pass as amended, Amendment # 1

upper

Jan 27, 2023

Introduced

Filed

upper

2 primary · 0 co-sponsors